Shopping Cart
- Remove All
- Your shopping cart is currently empty
XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | XL44, as an hRpn13 binder, triggers hRpn13-dependent apoptosis and limits cell viability via a PCLAF-dependent mechanism. It causes ubiquitin-dependent degradation of hRpn13 Pru and ubiquitin-independent degradation of specific KEN box-containing proteins [1]. |
In vitro | XL44, when applied at a concentration of 20 μM to RPMI 8226 cell lysates over a period of 4-24 hours, triggers apoptosis through an hRpn13-dependent mechanism and diminishes hRpn13Pru levels [1]. Western Blot Analysis confirms these findings [1]. |
Molecular Weight | 388.39 |
Formula | C23H17FN2O3 |
Cas No. | 2637949-91-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.